LGD-4033 Ligandrol SARMs for Bodybuilding

Bulking SARMS Raw Powder LGD-4033 （Ligandrol）Oral Anabolic Steroids CAS 1165910-22-4

LGD-4033 detail:

LGD-4033 Usage:
LGD is still fairly new (3-5 years), but the results have been very similar in studies and logs. LGD-4033 has undergone several recent studies and trials to find the best and safest way to use it. From these trials, the results have shown increases in lean body mass and decreases in body fat. There is also a significant increase in strength, well being, as well as healing possibilities.
LGD-4033 (Ligandrol) is a selective oral androgen receptor modulator (SARM) that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It is in a class of androgen receptor (AR) ligands that are tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss.
LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.

The Half life and Dosage of LGD-4033:
The half life of LGD is quite long compared to other SARMs – between 26 and 38 hours. LGD is extremely potent, so a small dose is all that is necessary – the average dose is 10mg per day, and length of cycle is typically 8 weeks. Nonetheless, the dosage range is subject to users discretion, going as low as 2mg per day and up to 20mg.
Regarding the adequate use of LGD in liquid form, it should be swallowed – simply squirt the liquid into the mouth, swallow immediately, then chase down with some juice or water as the taste can be unpleasant. It is not necessary to hold SARMs under the tongue, and you should never mix them in a cup with other liquids.
 
LGD-4033 Effect:
LGD-4033, a novel nonsteroidal, oral selective androgen receptor modulator, binds to the androgen receptor with high affinity and selectivity. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands.
LGD-4033 has recently completed a Phase I Multiple Ascending Dose study in healthy volunteers. This randomized, double-blind, placebo-controlled Phase I study established the safety and tolerability up to doses of 22 mg per day.

Related Hot selling Series:

Here we are not selling a product, just trying to make more clients have an access to top quality steroids powder, and get what they want!